12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice
Titli Nargis(University of Chicago), Raghavendra G. Mirmira(University of Chicago)
Cited by 1
Related Papers
Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice
|Journal of Clinical Investigation|2024|18
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice
|JCI Insight|2024|8
Characterization of lipoproteins in human placenta and fetal circulation as well as gestational changes in lipoprotein assembly and secretion in human and mouse placentas
|Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids|2023|5
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1